Loading clinical trials...
Loading clinical trials...
The CATALYST study is an implementation study that will characterize and assess the implementation of an enhanced service delivery package providing informed choice of pre-exposure prophylaxis (PrEP) ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
FHI 360
Collaborators
NCT07509853 · HIV Prevention, Substance Use, and more
NCT07512869 · HIV Prevention, Substance Use, and more
NCT07292792 · HIV Disease, HIV Prevention
NCT07002866 · HIV Prevention
NCT06745947 · HIV Prevention
Chulaimbo sub-country hospital
Kisumu
Migosi Health
Kisumu
Likoni Sub-country hospital
Mombasa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions